Bryant David Lim insider trades

Open-market stock purchases and sales by Bryant David Lim, CLO, CFO, Corp Sec. at Prelude Therapeutics Inc, from SEC Form 4 filings since Sep 10, 2018.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -24%.

Recent trades

DateStockTradeValue
Feb 4, 2026PRLD Prelude Therapeutics IncBought (not open market)—

Companies traded

  • PRLD Prelude Therapeutics Inc: 2 buys, last Feb 4, 2026
  • ACGN Aceragen, Inc: other filings, last Jan 20, 2023
  • IDRA Idera Pharmaceuticals, Inc: 1 buy, 5 sales, last Jan 6, 2023

Get free alerts when Bryant David Lim files a new trade →